Sak Katrin
a NGO Praeventio , Näituse 22-3, Tartu , Estonia.
Nutr Cancer. 2017 Nov-Dec;69(8):1119-1150. doi: 10.1080/01635581.2017.1367934. Epub 2017 Oct 30.
Several epidemiological findings have demonstrated that specific flavonoids can be responsible for reduction of the risk of certain cancer types. However, these results are still rather limited, inconclusive and controversial. Therefore, in this comprehensive review article the findings reported to date about the associations between dietary intake of individual flavonoid compounds and cancer incidence are compiled and analyzed. Also, the possible reasons for inconsistencies are brought forth and discussed. As diet is a potentially modifiable factor in our behavioral choices, further large-scale prospective studies with longer follow-up times, different populations, various doses and exposure timing as well as diverse well-controlled confounders are highly needed to confirm or disprove the current epidemiological knowledge about the role of flavonoids on cancer risk. Regarding the promising data to date, more research on bioavailability, metabolism and biological action mechanisms of these plant secondary metabolites is also encouraged.
多项流行病学研究结果表明,特定的黄酮类化合物可降低某些癌症类型的发病风险。然而,这些结果仍然相当有限、尚无定论且存在争议。因此,在这篇全面的综述文章中,我们对迄今为止报道的关于个体黄酮类化合物的膳食摄入量与癌症发病率之间关联的研究结果进行了汇总和分析。此外,还提出并讨论了结果不一致的可能原因。由于饮食是我们行为选择中一个潜在的可改变因素,因此迫切需要开展更多大规模的前瞻性研究,延长随访时间,纳入不同人群、不同剂量、不同暴露时间以及各种经过良好控制的混杂因素,以证实或反驳目前关于黄酮类化合物在癌症风险中作用的流行病学知识。鉴于目前已有一些有前景的数据,也鼓励对这些植物次生代谢产物的生物利用度、代谢和生物作用机制进行更多研究。